MYC and lymphoma: After a 4 h drug treatment, we noted a significant and dose-dependent decrease in c-MYC protein levels in multiple lymphoma cell lines, correlating with a concurrent decrease in c-MYC mRNA expression (Figure 4A and B, respectively).